Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 849


26th Annual GP2A Medicinal Chemistry Conference & 32nd Journées Franco-Belges de Pharmacochimie.

Dallemagne P, Rochais C, Marchand P, Besson T.

Pharmaceuticals (Basel). 2019 May 16;12(2). pii: E73. doi: 10.3390/ph12020073.


Colloidal Silver Induces Cytoskeleton Reorganization and E-Cadherin Recruitment at Cell-Cell Contacts in HaCaT Cells.

Montano E, Vivo M, Guarino AM, di Martino O, Di Luccia B, Calabrò V, Caserta S, Pollice A.

Pharmaceuticals (Basel). 2019 May 15;12(2). pii: E72. doi: 10.3390/ph12020072.


VitalSign6: A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression.

Trivedi MH, Jha MK, Kahalnik F, Pipes R, Levinson S, Lawson T, Rush AJ, Trombello JM, Grannemann B, Tovian C, Kinney R, Clark EW, Greer TL.

Pharmaceuticals (Basel). 2019 May 14;12(2). pii: E71. doi: 10.3390/ph12020071.


Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions.

Tangudu NK, Buth N, Strnad P, Cirstea IC, Spasić MV.

Pharmaceuticals (Basel). 2019 May 7;12(2). pii: E70. doi: 10.3390/ph12020070.


Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases.

Rodrigues DA, Sagrillo FS, Fraga CAM.

Pharmaceuticals (Basel). 2019 May 6;12(2). pii: E69. doi: 10.3390/ph12020069.


Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

De Silva SF, Alcorn J.

Pharmaceuticals (Basel). 2019 May 5;12(2). pii: E68. doi: 10.3390/ph12020068. Review.


Targeting the Serine Pathway: A Promising Approach against Tuberculosis?

Haufroid M, Wouters J.

Pharmaceuticals (Basel). 2019 Apr 30;12(2). pii: E66. doi: 10.3390/ph12020066.


Filling the Gap: Neural Stem Cells as A Promising Therapy for Spinal Cord Injury.

Pereira IM, Marote A, Salgado AJ, Silva NA.

Pharmaceuticals (Basel). 2019 Apr 29;12(2). pii: E65. doi: 10.3390/ph12020065. Review.


Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring.

Paneth A, Płonka W, Paneth P.

Pharmaceuticals (Basel). 2019 Apr 24;12(2). pii: E64. doi: 10.3390/ph12020064.


Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data.

Schneider D, Oskamp A, Holschbach M, Neumaier B, Bauer A, Bier D.

Pharmaceuticals (Basel). 2019 Apr 14;12(2). pii: E57. doi: 10.3390/ph12020057.


Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines.

Durães F, Sousa E.

Pharmaceuticals (Basel). 2019 Apr 21;12(2). pii: E63. doi: 10.3390/ph12020063.


Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase.

Singh K, Sarafianos SG, Sönnerborg A.

Pharmaceuticals (Basel). 2019 Apr 20;12(2). pii: E62. doi: 10.3390/ph12020062. Review.


Hierarchical Virtual Screening of Potential Insectides Inhibitors of Acetylcholinesterase and Juvenile Hormone from Temephos.

V da Costa G, Ferreira EFB, da S Ramos R, B da Silva L, M F de Sá E, K P da Silva A, M Lobato C, N P Souto R, T de P da Silva CH, B Federico L, M C Rosa J, B R Dos Santos C.

Pharmaceuticals (Basel). 2019 Apr 18;12(2). pii: E61. doi: 10.3390/ph12020061.


Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches.

Souza INO, Barros-Aragão FGQ, Frost PS, Figueiredo CP, Clarke JR.

Pharmaceuticals (Basel). 2019 Apr 17;12(2). pii: E60. doi: 10.3390/ph12020060. Review.


Insights into the Molecular Mechanisms of Eg5 Inhibition by (+)-Morelloflavone.

Ogunwa TH, Laudadio E, Galeazzi R, Miyanishi T.

Pharmaceuticals (Basel). 2019 Apr 16;12(2). pii: E58. doi: 10.3390/ph12020058.


The Importance of Iron Status for Young Children in Low- and Middle-Income Countries: A Narrative Review.

Armitage AE, Moretti D.

Pharmaceuticals (Basel). 2019 Apr 16;12(2). pii: E59. doi: 10.3390/ph12020059. Review.


Protective Effect of Cashew Gum (Anacardium occidentale L.) on 5-Fluorouracil-Induced Intestinal Mucositis.

de Miranda JAL, Barreto JEF, Martins DS, de Souza Pimentel PV, da Silva Costa DV, E Silva RR, de Souza LKM, de Lima CNC, Rocha JA, de Freitas APF, da Silva DA, Scafuri AG, de Leitão RFC, de Castro Brito GA, Medeiros JVR, Cerqueira GS.

Pharmaceuticals (Basel). 2019 Apr 3;12(2). pii: E51. doi: 10.3390/ph12020051.


CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells.

Ahmed RL, Shaughnessy DP, Knutson TP, Vogel RI, Ahmed K, Kren BT, Trembley JH.

Pharmaceuticals (Basel). 2019 Apr 2;12(2). pii: E50. doi: 10.3390/ph12020050.


3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells.

Wang S, Malebari AM, Greene TF, O'Boyle NM, Fayne D, Nathwani SM, Twamley B, McCabe T, Keely NO, Zisterer DM, Meegan MJ.

Pharmaceuticals (Basel). 2019 Apr 11;12(2). pii: E56. doi: 10.3390/ph12020056.

Supplemental Content

Loading ...
Support Center